UCLA Cancer Center Licenses Rosetta's Resolver Software | GenomeWeb
NEW YORK (GenomeWeb News) — Rosetta Biosoftware has licensed its Resolver data-management software to the University of California, Los Angeles, the company said yesterday.
The school will use the software to handle data and analyze gene expression-profiling projects at the school’s Jonsson Comprehensive Cancer Center.
The JCCC is a treatment center that develops cancer therapies, including the breast cancer drug Herceptin, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.